Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Cells with a mutation in the gene called K-Ras-found in close to 30% of all cancers, but mostly those with worst prognosis, such as pancreatic cancer, colon cancer, and lung cancer-behave in ways that subvert the normal mechanisms of cell death, according to a cell-culture study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah.
Normal cells need survival signals from the tissue that surrounds them to remain alive. Other research has shown cells with the K-Ras mutation can survive and direct their own fate without these signals.
"Epithelia act as a skin that coat and protect most organs and are the sites where most solid tumors arise. Our previous studies showed that cells making up epithelia turnover at high rates due to mechanical pressure. When cells become too crowded (due to cells dividing), some cells pop out and die. The surprising thing we found in this study is that cells with the K-Ras mutations pop into the tissue and instead live," said Jody Rosenblatt, PhD, an HCI investigator and associate professor in the Department of Oncological Sciences at the University of Utah who co-authored the study. The process of popping cells from epithelia is called extrusion, and in normal cells, this leads to cell death to keep the number of cells under control. "Our new study suggests that this oncogene subverts the mechanism of normal cell death to promote invasion."
Another characteristic of cells with K-Ras mutations is that they consume parts of themselves (a process called autophagy) to keep up with the energy demands of rapid and unchecked cell division that the mutation causes.
"In normal cells that are about to extrude out, large quantities of an important signal called Sphingosine1-Phosphate (S1P) are present. Cells with the K-Ras mutation also produce S1P, but digest it through autophagy, so it cannot do its job and the cells extrude into the tissue," said Gloria Slattum, doctoral candidate in the Rosenblatt Lab and lead author of the article. "When we blocked autophagy using a common anti-malaria drug called Chloroquine, the cells with K-Ras mutations extruded out of the tissue and died, just as normal cells do."
The results were published online in the journal Current Biology.
Future study will investigate whether these cell-culture results hold true in an animal model. Co-authors of the article include Yapeng Gu, research associate in the Rosenblatt Lab, and Roger Sabbadini of LPath, Inc. The work was supported by a National Institute of Health (NIH) Innovator Award No. DP2 OD002056-01 and 1RO1GM102169-01, a NIH Developmental Biology Training Grant 5T32 HDO7491, and P30 CA042014 awarded to HCI for core facilities.
Autophagy in Oncogenic K-Ras Promotes Basal Extrusion of Epithelial Cells by Degrading S1P, Gloria Slattum, Yapeng Gu, Roger Sabbadini, Jody Rosenblatt, Current Biology, 19 December 2013 DOI 10.1016/j.cub.2013.11.029
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Genetics category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Institute, Huntsman Cancer. "The renegades of cell biology: Researchers discover why K-RAS gene mutations prove so deadly in cancer." Medical News Today. MediLexicon, Intl., 23 Dec. 2013. Web.
8 Mar. 2014. <http://www.medicalnewstoday.com/releases/270514>
Institute, H. (2013, December 23). "The renegades of cell biology: Researchers discover why K-RAS gene mutations prove so deadly in cancer." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270514.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.